Back to search

A phase II trial of pazopanib in relapsed/refractory small cell lung cancer (SCLC).

Leena Gandhi, Rebecca S. Heist, Joan Lucca, Jennifer S. Temel, Panos Fidias
DOI: 10.1200/jco.2012.30.15_suppl.7099
Journal of Clinical Oncology

Data up to Jan 2025

Published2012
Citations3
References0
Fields
MedicinePhysicsInternal medicineOncologySurgery

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
A phase II trial of pazopanib in relapsed/refractory small cell lung cancer (SCLC). (2012) – Journal of Clinical Oncology | Metascience Observatory Explorer